Michael R. Lovy
- Rheumatology top 5%
- Hematology top 10%
- Pathology and Forensic Medicine
- Hepatology top 10%
- Immunology
- Co-authors
- Gordon StarkebaumDaniel BurgeMichael SchiffTodd DeVriesJoel M. KremerEdward KeystoneShelly KafkaJames C. Steigerwald
- Topics
- Chronic Lymphocytic Leukemia Research (2 papers)Systemic Lupus Erythematosus Research (2 papers)Hepatitis C virus research (2 papers)
- Cited by
- RheumatologyHepatologyHematology
- Journals
- Annals of the Rheumatic DiseasesJournal of the American Academy of DermatologyDigestive Diseases and Sciences
- Partner nations
- United StatesCanada
In The Last Decade
Michael R. Lovy
8 papers receiving 363 citations
Peers
Comparison fields: 5 of 46
- Rheumatology 272
- Hematology 89
- Pathology and Forensic Medicine 74
- Hepatology 70
- Immunology 69
Countries citing papers authored by Michael R. Lovy
This map shows the geographic impact of Michael R. Lovy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Lovy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Lovy more than expected).
Fields of papers citing papers by Michael R. Lovy
This network shows the impact of papers produced by Michael R. Lovy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Lovy. The network helps show where Michael R. Lovy may publish in the future.
Co-authorship network of co-authors of Michael R. Lovy
This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Lovy. A scholar is included among the top collaborators of Michael R. Lovy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Lovy. Michael R. Lovy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 227 | |
| 3 | 5 | |
| 4 | Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. | 93 |
| 5 | 46 | |
| 6 | 2 | |
| 7 | Advantages of the Crithidia assay in SLE. | 4 |
| 8 | Hyperviscosity syndrome complicating rheumatoid arthritis: report of two additional cases and review of the literature. | 4 |
| 9 | 11 |
About Michael R. Lovy
Michael R. Lovy is a scholar working on Dermatology, Hepatology and Physiology, having authored 9 papers that have together received 392 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Rheumatology (272 citations), Hepatology (70 citations) and Hematology (89 citations). Michael R. Lovy has collaborated with scholars based in United States and Canada. Frequent co-authors include Gordon Starkebaum, Daniel Burge, Michael Schiff, Todd DeVries, Joel M. Kremer, Edward Keystone, Shelly Kafka, James C. Steigerwald, Daryl MacCarter and Gilbert B. Bluhm. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.